Medicover Hospital has introduced advanced Urodynamic Study (UDS) services, a diagnostic tool designed to improve the assessment and management of bladder and urinary tract disorders. The new facility allows physicians to evaluate the function of the bladder, sphincters, and urethra as they store and release urine.
The launch of UDS comes as bladder-related conditions become increasingly prevalent, influenced by factors such as aging, lifestyle choices, diabetes, prostate enlargement, childbirth, menopause, and neurological disorders. The hospital stated the expanded diagnostic capabilities will provide more comprehensive testing.
Urodynamic studies differ from standard imaging techniques, which primarily identify structural abnormalities. UDS assesses bladder function and pressure during both the filling and emptying phases, offering detailed insights into urine flow, bladder control, and muscle coordination.
The UDS process incorporates several specialized tests. Uroflowmetry measures the volume and speed of urine flow. Post-Void Residual (PVR) measurement determines the amount of urine remaining in the bladder after urination, utilizing ultrasound or a catheter. Cystometry evaluates bladder capacity and pressure by gradually filling the bladder with sterile fluid. A Pressure Flow Study records the pressure needed to urinate and the corresponding flow rate, helping to identify potential obstructions or weak bladder muscles. Electromyography (EMG) monitors nerve and muscle activity around the bladder and sphincters to assess coordination. Video Urodynamics combines pressure measurements with real-time X-ray or ultrasound imaging to visualize bladder shape and function.
According to Dr. Vikas Bhise, a Urologist at Medicover Hospital, UDS is typically recommended when initial treatments fail to alleviate symptoms or when a detailed evaluation is needed before surgical intervention. Common indications for UDS include urine leakage, frequent or urgent urination, painful urination, recurrent urinary tract infections, difficulty starting urination, or a persistent feeling of incomplete bladder emptying. Untreated conditions can lead to repeated infections, kidney damage, and a diminished quality of life.
The procedure generally involves minimal discomfort, although catheter insertion may cause slight stinging. Patients may experience minimal blood in their urine for up to 48 hours following the test, which can be alleviated by drinking plenty of water. Doctors may advise patients to arrive with a full bladder and temporarily discontinue certain medications for overactive bladder before the procedure.
Dr. Sanish Shringarpure, a Urologist and Andrologist at the hospital, emphasized that UDS facilitates precise treatment planning and can help avoid unnecessary medication or surgery. He noted the test is particularly valuable for patients with long-standing symptoms, those who have not responded to previous treatments, or those undergoing pre-surgical evaluation. He also highlighted that many individuals mistakenly attribute urinary problems to normal aging and may benefit from identifying the underlying cause through UDS.
Sandip Joshi, Centre Head at Medicover Hospital, stated the introduction of UDS reflects the hospital’s commitment to expanding its advanced diagnostic services, aiming to improve clinical outcomes and enhance patients’ quality of life.
